SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-23-000024
Filing Date
2023-11-09
Accepted
2023-11-09 16:01:36
Documents
64
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sls-20230930.htm   iXBRL 10-Q 783396
2 EX-31.1 sls-20230930ex311.htm EX-31.1 8220
3 EX-31.2 sls-20230930ex312.htm EX-31.2 8207
4 EX-32.1 sls-20230930ex321.htm EX-32.1 6586
5 EX-32.2 sls-20230930ex322.htm EX-32.2 6576
11 sls-20230930_g1.jpg GRAPHIC 30719
  Complete submission text file 0001390478-23-000024.txt   4643993

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sls-20230930.xsd EX-101.SCH 39283
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sls-20230930_cal.xml EX-101.CAL 48165
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sls-20230930_def.xml EX-101.DEF 151373
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sls-20230930_lab.xml EX-101.LAB 455784
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sls-20230930_pre.xml EX-101.PRE 303004
58 EXTRACTED XBRL INSTANCE DOCUMENT sls-20230930_htm.xml XML 562488
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 231392157
SIC: 2834 Pharmaceutical Preparations